NCT06463639View on ClinicalTrials.gov

FLT3 Clonal Evolution in Patients With Acute Myeloid Leukemia

CompletedOBSERVATIONAL

Enrollment

1,213

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

October 31, 2023

Study Completion Date

June 10, 2024

Conditions

Acute Myeloid Leukemia

Trial Locations (1)

100

National Taiwan University Hospital, Taipei

Sponsors

Collaborators (1)

Astellas Pharma Inc

All Listed Sponsors

collaborator

Astellas Pharma Inc

INDUSTRY

lead

National Taiwan University Hospital

OTHER